Latest Articles

Publication Date
MicroRNA Crossroads in PCOS and Endometriosis.

In the intricate landscape of health disorders in women, polycystic ovary syndrome and endometriosis stand out. Despite their complete etiology being unknown, their impact on women's health and link to …

Published: Dec. 23, 2025, midnight
The Impact of Central Sensitization on Patients Perceived Improvement and Quality of Life Following Surgery for Chronic Pelvic Pain: A Pilot Study.

To assess whether higher baseline Central Sensitization Inventory (CSI) scores are linked to quality-of-life outcomes and patient's impression of improvement after surgery for chronic pelvic pain.

Published: Dec. 23, 2025, midnight
Endometriosis: From Genes to Global Burden.

Endometriosis has a significant impact on the social, psychological, psychosomatic, and physical aspects of women's lives. There is increasing evidence that endometriosis has to be seen as a systemic and …

Published: Dec. 23, 2025, midnight
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial - marketscreener.com

AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial marketscreener.com

Published: Dec. 22, 2025, 11:40 a.m.
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer - Nasdaq

ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer Nasdaq

Published: Dec. 22, 2025, 11:34 a.m.
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer - Nature

Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer Nature

Published: Dec. 22, 2025, 10:55 a.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa

First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa

Published: Dec. 22, 2025, 8:15 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal

Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com

Published: Dec. 22, 2025, 7:30 a.m.
Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed - Women's Health

Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed Women's Health

Published: Dec. 22, 2025, 6:01 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!